Claro Advisors’s Avita Medical RCEL Stock Holding History

Claro Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,500	Closed	-$114K	–	182
2019 Q4	$114K	Buy	+2,500	New	+$104K	0.09%	168

Other funds holding RCEL

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Claro Advisors's RCEL Position: Q1 2020 in Review

Claro Advisors sold out of Avita Medical (RCEL) in Q1 2020, closing a stake of 2,500 shares — an estimated $114K sold.

Claro Advisors first reported a position in RCEL in Q4 2019 and held it in 1 quarter. The position peaked at $114K in Q4 2019. 36 funds tracked by Wall St. Rank hold RCEL as of Q1 2020.

Claro Advisors reported no remaining Avita Medical position as of Q1 2020 after selling out during the quarter.
Claro Advisors sold 2,500 Avita Medical shares in Q1 2020, an estimated $114K.
Claro Advisors first reported a position in Avita Medical in Q4 2019 and held it in 1 quarter.
Claro Advisors's Avita Medical position peaked at $114K in Q4 2019.
36 funds tracked by Wall St. Rank held Avita Medical as of Q1 2020.

Based on Claro Advisors's 13F filing for Q1 2020, filed 15 May 2020.